logo
Select company
Select metric
-24.37%EBIT Margin
VS
Market
21
Sector
52
Industry
32
History
100
$ 2.58Close
$ 2.12 - $ 4.93 52-Week Range
Ticker Information

Ticker

NXGL

Company Name

NEXGEL INC

Sector

Healthcare

Industry

Medical Instruments & Supplies

Exchange

NASDAQ

NEXGEL INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NXGL - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -2.84M-24.37%$ 11.67M
3/31/2025$ -3.06M-29.87%$ 10.23M
12/31/2024$ -3.2M-36.83%$ 8.69M
9/30/2024$ -3.46M-51.46%$ 6.73M
6/30/2024$ -3.34M-66.6%$ 5.01M
3/31/2024$ -3.17M-66.87%$ 4.74M
12/31/2023$ -3.14M-76.84%$ 4.09M
9/30/2023$ -2.69M-76.22%$ 3.53M
6/30/2023$ -3.13M-108.72%$ 2.88M
3/31/2023$ -3.13M-137.75%$ 2.27M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NEXGEL INC's latest trailing twelve months (TTM) EBIT % stands at -251.13%.
  • Over the past 5 years, NEXGEL INC's average EBIT % has been -142.39%.
  • The median EBIT % for NEXGEL INC during this period was -145.6%
  • NEXGEL INC reached its highest EBIT % over the past 5 years at -24.37%.
  • The lowest EBIT % recorded by NEXGEL INC in the same timeframe -334.72%

NEXGEL INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
CRIS : CURIS INC -341.25%BCAB : BIOATLA INC -541.05%EKSO : EKSO BIONICS HOLDINGS INC -73.78%HCTI : HEALTHCARE TRIANGLE INC -36.17%NEPH : NEPHROS INC 8.1%VSEE : VSEE HEALTH INC -567.43%CARM : CARISMA THERAPEUTICS INC -458.6%FEMY : FEMASYS INC -1017.66%POCI : PRECISION OPTICS CORPORATION INC -29.08%CSCIF : COSCIENS BIOPHARMA INC -187.81%

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for NEXGEL INC is calculated as follows: EBIT [ $ -1.88M ] / Revenues [ $ 749K ]
(=) EBIT % [ -251.13% ]

NXGL - EBIT Margin, Last 5 years

-334.72%

Minimum

Dec 31, 2020

-24.37%

Maximum

Jun 30, 2025

-142.39%

Average

-145.6%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.56% with a standard deviation of 23.95%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.56%
median9.02%
std23.95%